Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Sampharindo Putra Trading is an Indonesian pharmaceutical distribution company that operates as the trading and marketing arm of the Sampharindo Group. The company specializes in the supply of generic pharmaceuticals, over-the-counter (OTC) medications, and nutritional supplements across the Indonesian domestic market. Its product portfolio includes a variety of respiratory treatments, analgesics, and multivitamins, featuring notable local brands such as Samcodin and Samcorbex. The company works in close coordination with its sister manufacturing entity, PT Sampharindo Perdana, to ensure the availability of affordable healthcare products in pharmacies and hospitals. It maintains a significant presence in the Indonesian healthcare supply chain, focusing on high-volume generic products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sampharindo Putra Trading.